Chlorhexidine
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Chlorhexidine
Chlorhexidine: Known uses and market status in Australia
Summary
The TxGNN model has no candidate with a score of 0.99 or higher for Chlorhexidine, so there is currently no new predicted indication. The drug’s recorded uses are listed below. These are the drug’s own recorded uses, not model candidates.
Quick overview
| Item | Content |
|---|---|
| New predicted indications | None (no model candidate scored 0.99 or higher) |
| Known uses recorded for this drug | 1 |
| Evidence level | Not applicable |
| Australia Market Status | Listed on the PBS Schedule (2 of 2 items) – TGA (ARTG) registration status is not included in this data |
| Number of PBS Items | 2 (valid: 2) |
Known uses recorded for this drug
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| none | none |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| gingivitis |
Australia Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 4161B | Plaqacide | Mouth wash 2 mg per mL (0.2%), 250 mL | Valid |
| 183P | nan | nan | Valid |
Safety Considerations
- Drug Interactions: The interaction screen returned 100 potential interacting drugs, but none has a severity level assigned. Examples include acetaminophen, atenolol, amlodipine, alprazolam, chloramphenicol, levothyroxine, celecoxib and cephalexin. These should be interpreted cautiously.
Please refer to the TGA-approved Product Information (PI) for warnings, precautions and full contraindications.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.